Nanocarrier-Mediated Photochemotherapy and Photoradiotherapy

Area of Science:

• Biomedical Engineering
• Oncology
• Nanotechnology

Background:

• Photothermal therapy (PTT) and photodynamic therapy (PDT) are emerging light-based treatments with minimal side effects.
• Current limitations show that PTT and PDT alone rarely achieve complete tumor elimination in preclinical studies.
• Conventional chemotherapy and radiotherapy have significant adverse effects.

Purpose of the Study:

• To review recent advancements in combining PTT and PDT with chemotherapy or radiotherapy.
• To highlight the role of nanocarriers in facilitating these combined therapeutic approaches.
• To discuss the potential of photochemotherapy and photoradiotherapy for enhanced cancer treatment.

Main Methods:

• Literature review of recent preclinical studies.
• Focus on nanocarrier-mediated drug delivery systems.
• Analysis of combined phototherapy, chemotherapy, and radiotherapy strategies.

Main Results:

• Nanocarriers effectively enable combination therapies, improving therapeutic efficacy.
• Combined treatments demonstrate enhanced tumor elimination compared to monotherapies.
• Synergistic effects reduce side effects associated with conventional treatments.

Conclusions:

• Combination of PTT/PDT with chemotherapy/radiotherapy, facilitated by nanocarriers, offers a promising strategy.
• Photochemotherapy and photoradiotherapy represent significant advancements in cancer treatment.
• Further research into nanocarrier-based combined therapies is warranted for clinical translation.